25 year spotlight: Dr Louise Nott

Louise Nott

“I joined the AGITG as an advanced trainee 10 years ago.   I am proud to be part of this world-class multi-disciplinary research group made up of inspirational and talented people who share the common goal of improving outcomes for all patients with gastrointestinal cancers.   Over this time I have participated in approximately 22 AGITG clinical trials as a co- or principal investigator.  

Importantly, I have been able to offer these trials to my patients close to home in a regional hospital where they can be supported by their families and friends.     The AGITG supports participation of regional/rural trials centres ensuring access to clinical trials is not dependent on living in a large city; something I am passionate about.   The group also provides incredible mentoring and preceptorship to junior members empowering them be involved in GI clinical trials in their own hospitals and beyond.

Above all, the AGITG are a group of kind-hearted, passionate and driven individuals who are inspirational in the way they have and continue to make a difference to the lives of patients with GI cancers.”

Dr Louise Nott is a medical oncologist with expertise in lung cancer, gastro-intestinal cancer and prostate cancer. She is a consultant medical oncologist in the Haematology and Oncology Department at the Royal Hobart Hospital, where she has been since 2007. Prior to this, Louise was a medical oncology registrar at the Queen Elizabeth Hospital in Adelaide.

Louise completed her Bachelor of Medicine, Bachelor of Surgery at the University of Tasmania in 1997 before becoming a Fellow of the Royal Australasian College of Physicians. She is an Associate of the University of Tasmania and is also affiliated with St John’s Hospital.

She works on clinical trials with the Menzies Research Institute, testing new treatments for cancer and blood disease. The Menzies Research Institute focuses on the major diseases affecting the Tasmanian community and aims to translate research into clinical and policy actions.

Louise recently presented on the latest advancements in treatments and research into GI cancer at an Engage Community Forum in Hobart. Engage Forums are designed to bring together medical professionals and patients of GI Cancer (as well as their carers) to share advice and information, and build supportive networks.

In 2015, she co-convened the Annual Scientific Meeting of the Clinical Oncology Society of Australia (COSA). COSA is the peak national body representing all professionals whose work includes the care of cancer patients. The 2015 ASM focused on rare cancers and the challenges they pose.

Donate Now